Guerrieri Davide, Rapp Emma, Roman Markus, Druid Henrik, Kronstrand Robert
Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, 58758Linköping, Sweden.
Department of Oncology-Pathology, Karolinska Institutet, 17177 Stockholm, Sweden.
J Anal Toxicol. 2017 Apr 1;41(3):242-249. doi: 10.1093/jat/bkw129.
Over the course of 4 months in 2015 and 2016, a cluster of seven fatal intoxications involving the opioid-analogue furanylfentanyl occurred in Sweden; toxicological analysis showed presence of furanylfentanyl either as the only drug or in combination with other illicit substances. Previous publications have only reported non-lethal furanylfentanyl intoxications. In the cases presented here, furanylfentanyl intoxication-alone or in combination with other drugs-was determined to be the cause of death by the responsible pathologist. All victims were young (24-37 years old) males, five of which had a well-documented history of drug abuse. Femoral blood concentration of furanylfentanyl ranged from 0.41 ng/g to 2.47 ng/g blood. Five cases presented a complex panel of drugs of abuse and prescription drugs. Moreover, in five cases the concurrent presence of pregabalin corroborates previous observations indicating pregabalin as a possible contributing factor in polydrug intoxications. We conclude that it is difficult to establish a specific lethal concentration of furanylfentanyl, due to incompletely known effects of possible pharmacokinetic and pharmacodynamic interactions with other drugs, as well as to the unknown degree of tolerance to opioids. We suggest that a full toxicological screening-to assess the possibility of drug interactions-together with segmental hair analysis regarding opioids-to estimate the level of opioid tolerance-be carried out to assist in the interpretation of cases involving synthetic opioids such as furanylfentanyl.
在2015年和2016年的4个月时间里,瑞典发生了7起涉及阿片类药物类似物呋喃芬太尼的致命中毒事件;毒理学分析表明,呋喃芬太尼要么是唯一的药物,要么与其他非法物质混合存在。以往的出版物仅报道过非致命性的呋喃芬太尼中毒事件。在本文介绍的案例中,负责的病理学家确定,呋喃芬太尼中毒(单独或与其他药物混合)是死亡原因。所有受害者均为年轻男性(24 - 37岁),其中5人有确凿的药物滥用史。呋喃芬太尼在股静脉血中的浓度范围为0.41纳克/克至2.47纳克/克血液。5例呈现出复杂的滥用药物和处方药组合。此外,在5例中同时存在普瑞巴林,这证实了之前的观察结果,即普瑞巴林可能是多药中毒的一个促成因素。我们得出结论,由于与其他药物可能存在的药代动力学和药效学相互作用的影响不完全清楚,以及对阿片类药物的耐受程度未知,因此很难确定呋喃芬太尼的特定致死浓度。我们建议进行全面的毒理学筛查以评估药物相互作用的可能性,同时进行关于阿片类药物的分段毛发分析以估计阿片类药物的耐受水平,以协助解释涉及呋喃芬太尼等合成阿片类药物的案例。